Reversing age: dual species measurement of epigenetic age with a single clock | Lifespan Edge

Lifespan Edge Search

This study explores the effects of young blood plasma on aging at the epigenetic level in rats, specifically examining whether plasma treatment can alter the epigenetic clock, a key molecular biomarker of aging. Researchers developed six epigenetic clocks based on DNA methylation for various rat tissues, including pan-tissue, brain, liver, and blood clocks, as well as clocks applicable to both human and rat tissues.

Key findings include:

  • Plasma treatment significantly reduced the epigenetic ages of blood, heart, and liver tissues, with a smaller yet notable effect in the hypothalamus.
  • The treatment improved organ function, as shown by various biochemical and physiological biomarkers, and enhanced cognitive function based on behavioral tests.
  • Cellular senescence, which is typically unrelated to epigenetic aging, was also notably reduced in vital organs.

Overall, this study suggests that plasma-derived treatment can effectively reverse aging in multiple organs according to epigenetic clocks and other aging markers, supporting its potential for rejuvenative therapy.